ImmPACT Bio
Shirin Ghavam, MS. OD., joined ImmPACT Bio in September 2022 and serves as Head of Program Management. She brings with her 20 years of Biotech-Pharmaceutical experience spanning all phases of the product lifecycle, from pre-clinical through commercialization and post- marketed products, at both large pharmaceuticals as well as startups.
Shirin has a proven track record of empowering cross-functional teams to develop and execute best-in-class innovative products that transform the lives of patients globally. She is a collaborative action-oriented leader who uses strategic planning, employee empowerment coupled with corporate values to drive collaboration and achieve long lasting results.
This person is not in any offices
ImmPACT Bio
ImmPACT Bio is dedicated to the discovery of transformative CAR-T cell therapies for cancer patients who have exhausted their treatment options.